Verona Pharma PLC (VRNA)
46.19
-0.53
(-1.13%)
USD |
NASDAQ |
Dec 27, 16:00
46.22
+0.03
(+0.06%)
After-Hours: 20:00
Verona Pharma Cash from Investing (Quarterly): 0.00 for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| TC BioPharm (Holdings) PLC | -0.0379M |
| Adaptimmune Therapeutics PLC | -66.02M |
| Biodexa Pharmaceuticals PLC | -- |
| Autolus Therapeutics PLC | -9.589M |
| Bicycle Therapeutics PLC | -0.435M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -62.66M |
| Cash from Financing (Quarterly) | -7.087M |
| Free Cash Flow | -103.81M |
| Free Cash Flow Per Share (Quarterly) | -0.7688 |
| Free Cash Flow to Equity (Quarterly) | -62.98M |
| Free Cash Flow to Firm (Quarterly) | -57.49M |
| Free Cash Flow Yield | -2.78% |